SEC Form 4 · accession 0001572426-15-000052
Nexvet Biopharma plc · NVET
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
A later amendment supersedes this filing — read the amendment. The figures below are kept as originally reported (version chain, not an overwrite).
Reporting owner
George W Gunn
Director
Period of report
May 18, 2015
Accepted (ET)
May 20, 2015 · 6:39 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001618561
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| OptionsF1 | $0.125 | May 18, 2015 | A | 6,000 | A | May 18, 2015 | May 18, 2020 | Ordinary Shares | 6,000 | 6,000 | D |
| Options | $0.125 | May 18, 2015 | A | 900 | A | Jun 30, 2015 | May 18, 2020 | Ordinary Shares | 900 | 900 | D |
Explanation of responses
- F1Options vested and became exercisable with respect to 500 shares on 5/18/15, and will vest and become exercisable with respect to 500 shares on each of 6/30/15, 9/30/15, 12/31/15, 3/31/16, 6/30/16, 9/30/16, 12/31/16, 3/31/17, 6/30/17, 9/30/17, 12/31/17, 3/31/18, 6/30/18, 9/30/18 and 12/31/18, in each case subject to payment of the nominal value per share to Issuer.